Literature DB >> 11134325

Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

F Mortreux1, M Kazanji, A S Gabet, B de Thoisy, E Wattel.   

Abstract

After experimental infection of squirrel monkeys (Saimiri sciureus) with human T-cell leukemia virus type 1 (HTLV-1)-infected cells, the virus is transcribed only transiently in circulating blood, spleen, and lymph nodes. Stable disappearance of viral expression occurs at 2 to 3 weeks after inoculation. This coincides with the development of the anti-HTLV-1 immune response and persistent detection of the provirus in peripheral blood mononuclear cells (PBMCs). In this study, the HTLV-1 replication pattern was analyzed over time in PBMCs and various organs from two HTLV-1-infected squirrel monkeys. Real-time quantitative PCR confirmed that PBMCs and lymphoid organs constitute the major reservoirs for HTLV-1. The PCR amplification of HTLV-1 flanking sequences from PBMCs evidenced a pattern of clonal expansion of infected cells identical to that observed in humans. Dissemination of the virus in body compartments appeared to result from cellular transport of the integrated provirus. The circulating proviral burden increased as a function of time in one animal studied over a period of 4 years. The high proviral loads observed in the last samples resulted from the accumulation of infected cells via the extensive proliferation of a restricted number of persistent clones on a background of polyclonally expanded HTLV-1-positive cells. Therefore, HTLV-1 primary infection in squirrel monkeys is a two-step process involving a transient phase of reverse transcription followed by persistent multiplication of infected cells. This suggests that the choice of the target for blocking HTLV-1 replication might depend on the stage of infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134325      PMCID: PMC114008          DOI: 10.1128/JVI.75.2.1083-1089.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.

Authors:  E Hanon; S Hall; G P Taylor; M Saito; R Davis; Y Tanaka; K Usuku; M Osame; J N Weber; C R Bangham
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses.

Authors:  M Kazanji; A Ureta-Vidal; S Ozden; F Tangy; B de Thoisy; L Fiette; A Talarmin; A Gessain; G de Thé
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.

Authors:  J T Bartoe; B Albrecht; N D Collins; M D Robek; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Lymphocyte alveolitis in HAM/TSP patients. Preliminary report.

Authors:  K Mattos; C Queiroz; A C Peçanha-Martins; L Publio; V Vinhas; A Melo
Journal:  Arq Neuropsiquiatr       Date:  1993-03       Impact factor: 1.420

5.  Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells.

Authors:  F Santiago; E Clark; S Chong; C Molina; F Mozafari; R Mahieux; M Fujii; N Azimi; F Kashanchi
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells.

Authors:  M Cavrois; A Gessain; O Gout; S Wain-Hobson; E Wattel
Journal:  J Infect Dis       Date:  2000-09-06       Impact factor: 5.226

7.  Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo.

Authors:  I Leclercq; F Mortreux; M Cavrois; A Leroy; A Gessain; S Wain-Hobson; E Wattel
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

Authors:  A S Gabet; F Mortreux; A Talarmin; Y Plumelle; I Leclercq; A Leroy; A Gessain; E Clity; M Joubert; E Wattel
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

9.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

10.  Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission.

Authors:  K Yamanouchi; K Kinoshita; R Moriuchi; S Katamine; T Amagasaki; S Ikeda; M Ichimaru; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1985-06
View more
  23 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

3.  Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.

Authors:  Seung-Jae Kim; Amrithraj M Nair; Soledad Fernandez; Lawrence Mathes; Michael D Lairmore
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 4.  Endemic Viruses of Squirrel Monkeys (Saimiri spp.).

Authors:  Donna L Rogers; Gloria B McClure; Julio C Ruiz; Christian R Abee; John A Vanchiere
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

5.  The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Authors:  Nicolas A Gillet; Nirav Malani; Anat Melamed; Niall Gormley; Richard Carter; David Bentley; Charles Berry; Frederic D Bushman; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

6.  Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Authors:  Rashade A H Haynes; Andrew J Phipps; Brenda Yamamoto; Patrick Green; Michael D Lairmore
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

8.  Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.

Authors:  Linda Zane; David Sibon; Lionel Jeannin; Marc Zandecki; Marie-Hélène Delfau-Larue; Antoine Gessain; Olivier Gout; Christiane Pinatel; Agnès Lançon; Franck Mortreux; Eric Wattel
Journal:  Retrovirology       Date:  2010-03-11       Impact factor: 4.602

9.  Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.

Authors:  Samira Rabaaoui; Fatima Zouhiri; Agnès Lançon; Hervé Leh; Jean d'Angelo; Eric Wattel
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

10.  Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.

Authors:  Horacio Gómez-Acevedo; Michael Y Li; Steven Jacobson
Journal:  Bull Math Biol       Date:  2009-12-30       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.